CTLA4 and myocarditis: For example, Salem et al. presented a case in which the use of abatacept (a cytotoxic T-lymphocyte–associated antigen 4 [CTLA-4] agonist) led to the resolution of severe, glucocorticoid-refractory ICI myocarditis [74].